Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' SHAW LM' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 98 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Mercurio, AM; Bachelder, RE; Chung, J; O'Connor, KL; Rabinovitz, I; Shaw, LM; Tani, T
      Integrin laminin receptors and breast carcinoma progression

      JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
    2. Mercurio, AM; Rabinovitz, I; Shaw, LM
      The alpha 6 beta 4 integrin and epithelial cell migration

      CURRENT OPINION IN CELL BIOLOGY
    3. Shaw, LM
      Identification of insulin receptor substrate 1 (IRS-1) and IRS-2 as signaling intermediates in the alpha 6 beta 4 integrin-dependent activation of phosphoinositide 3-OH kinase and promotion of invasion

      MOLECULAR AND CELLULAR BIOLOGY
    4. Shaw, LM; Holt, DW; Oellerich, M; Meiser, B; van Gelder, T
      Current issues in therapeutic drug monitoring of mycophenolic acid: Reportof a roundtable discussion

      THERAPEUTIC DRUG MONITORING
    5. Venkataramanan, R; Shaw, LM; Sarkozi, L; Mullins, R; Pirsch, J; MacFarlane, G; Scheller, D; Ersfeld, D; Frick, M; Fitzsimmons, WE; Virji, M; Jain, A; Brayman, KL; Shaked, A
      Clinical utility of monitoring tacrolimus blood concentrations in liver transplant patients

      JOURNAL OF CLINICAL PHARMACOLOGY
    6. Hale, A; Shaw, LM
      Women workers and the promise of ethical trade in the globalised garment industry: A serious beginning?

      ANTIPODE
    7. Shaw, LM; Korecka, M; DeNofrio, D; Brayman, KL
      Pharmacokinetic, pharmacodynamic, and outcome investigations as the basis for mycophenolic acid therapeutic drug monitoring in renal and heart transplant patients

      CLINICAL BIOCHEMISTRY
    8. Bachelder, RE; Crago, A; Chung, J; Wendt, MA; Shaw, LM; Robinson, G; Mercurio, AM
      Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells

      CANCER RESEARCH
    9. Bonner, HS; Shaw, LM
      Measurement of both protein-bound and total S-2-(3-aminopropylamino)ethanethiol (WR-1065) in blood by high-performance liquid chromatography

      JOURNAL OF CHROMATOGRAPHY B
    10. DeNofrio, D; Loh, E; Kao, A; Korecka, M; Pickering, FW; Craig, KA; Shaw, LM
      Mycophenolic acid concentrations are associated with cardiac allograft rejection

      JOURNAL OF HEART AND LUNG TRANSPLANTATION
    11. Shaw, LM; Kaplan, B; DeNofrio, D; Korecka, M; Brayman, KL
      Pharmacokinetics and concentration-control investigations of mycophenolic acid in adults after transplantation

      THERAPEUTIC DRUG MONITORING
    12. Meier-Kriesche, HU; Shaw, LM; Korecka, M; Kaplan, B
      Pharmacokinetics of mycophenolic acid in renal insufficiency

      THERAPEUTIC DRUG MONITORING
    13. Shaw, LM; Kaplan, B; Brayman, KL
      Introduction and overview

      CLINICAL THERAPEUTICS
    14. Shaw, LM; Korecka, M; Aradhye, S; Grossman, R; Bayer, L; Innes, C; Cucciara, A; Barker, C; Naji, A; Nicholls, A; Brayman, K
      Mycophenolic acid area under the curve values in African American and Caucasian renal transplant patients are comparable

      JOURNAL OF CLINICAL PHARMACOLOGY
    15. Majewski, M; Korecka, M; Kossev, P; Li, SY; Goldman, J; Moore, J; Silberstein, LE; Nowell, PC; Schuler, W; Shaw, LM; Wasik, MA
      The immunosuppressive macrolide RAD inhibits growth of human Epstein-Barr virus-transformed B lymphocytes in vitro and in vivo: A potential approach to prevention and treatment of posttransplant lymphoproliferative disorders

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    16. Holt, DW; Johnston, A; Kahan, BD; Morris, RG; Oellerich, M; Shaw, LM
      New approaches to cyclosporine monitoring raise further concerns about analytical techniques

      CLINICAL CHEMISTRY
    17. Guang, RJ; Ford, JL; Fu, YN; Li, YZ; Shaw, LM; Pardee, AB
      Drg-1 as a differentiation-related, putative metastatic suppressor gene inhuman colon cancer

      CANCER RESEARCH
    18. Markovic, N; Ness, RB; Cefilli, D; Grisso, JA; Stahmer, S; Shaw, LM
      Substance use measures among women in early pregnancy

      AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
    19. Shaw, LM
      Integrin function in breast carcinoma progression

      JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
    20. Tsiodras, S; Shin, RK; Christian, M; Shaw, LM; Sass, DA
      Anticholinergic toxicity associated with lupine seeds as a home remedy fordiabetes mellitus

      ANNALS OF EMERGENCY MEDICINE
    21. MacFarlane, GD; Shaw, LM; Venkataramanan, R; Mullins, R; Scheller, DG; Ersfeld, DL
      Analysis of whole blood tacrolimus concentrations in liver transplant patients exhibiting impaired liver function

      THERAPEUTIC DRUG MONITORING
    22. Shaw, LM; Holt, DW; Keown, P; Venkataramanan, R; Yatscoff, RW
      Current opinions on therapeutic drug monitoring of immunosuppressive drugs

      CLINICAL THERAPEUTICS
    23. Zhang, QA; Lee, B; Korecka, M; Li, G; Weyland, C; Eck, S; Gessain, A; Arima, N; Lessin, SR; Shaw, LM; Luger, S; Kamoun, M; Wasik, MA
      Differences in phosphorylation of the IL-2R associated JAK/STAT proteins between HTLV-I (+), IL-2-independent and IL-2-dependent cell lines and uncultured leukemic cells from patients with adult T-cell lymphoma/leukemia

      LEUKEMIA RESEARCH
    24. Shaw, LM; Bonner, HS; Schuchter, L; Schiller, J; Lieberman, R
      Pharmacokinetics of amifostine: Effects of dose and method of administration

      SEMINARS IN ONCOLOGY
    25. Kaplan, B; Meier-Kriesche, HU; Friedman, G; Mulgaonkar, S; Gruber, S; Korecka, M; Brayman, KL; Shaw, LM
      The effect of renal insufficiency on mycophenolic acid protein binding

      JOURNAL OF CLINICAL PHARMACOLOGY
    26. Grisso, JA; Schwarz, DF; Hirschinger, N; Sammel, M; Brensinger, C; Santanna, J; Lowe, RA; Anderson, E; Shaw, LM; Bethel, CA; Teeple, L
      Violent injuries among women in an urban area

      NEW ENGLAND JOURNAL OF MEDICINE
    27. Ness, RB; Grisso, JA; Hirschinger, N; Markovic, N; Shaw, LM; Day, NL; Kline, J
      Cocaine and tobacco use and the risk of spontaneous abortion

      NEW ENGLAND JOURNAL OF MEDICINE
    28. Chen, MS; Almeida, EAC; Huovila, APJ; Takahashi, Y; Shaw, LM; Mercurio, AM; White, JM
      Evidence that distinct states of the integrin alpha 6 beta 1 interact withlaminin and an ADAM

      JOURNAL OF CELL BIOLOGY
    29. MacFarlane, GD; Scheller, DG; Ersfeld, DL; Shaw, LM; Venkatarmanan, R; Sarkozi, L; Mullins, R; Fox, BR
      Analytical validation of the PRO-Trac II ELISA for the determination of tacrolimus (FK506) in whole blood

      CLINICAL CHEMISTRY
    30. Korecka, M; Nikolic, D; van Breemen, RB; Shaw, LM
      The apparent inhibition of inosine monophosphate dehydrogenase by mycophenolic acid glucuronide is attributable to the presence of trace quantities of mycophenolic acid

      CLINICAL CHEMISTRY
    31. Shaw, LM
      Disgraceful sideshow - Opening the lost tombs of Egypt

      ARCHAEOLOGY
    32. SHAW LM; TOKER A; MERCURIO AM
      PROTEIN-KINASE-C-EPSILON IS INVOLVED IN THE PHOSPHOINOSITIDE 3-OH KINASE-DEPENDENT PROMOTION OF CARCINOMA INVASION BY THE ALPHA-6-BETA-4 INTEGRIN

      Molecular biology of the cell
    33. WASIK MA; NOWAK I; ZHANG Q; SHAW LM
      SUPPRESSION OF PROLIFERATION AND PHOSPHORYLATION OF JAK3 AND STAT5 INMALIGNANT T-CELL LYMPHOMA-CELLS BY DERIVATIVES OF OCTYLAMINO-UNDECYL-DIMETHYLXANTHINE

      Leukemia & lymphoma
    34. Huang, K; Vaughn, DJ; Shaw, LM; Recio, A; Bonner, HS; Haller, DG
      A phase II trial and pharmacokinetic analysis of 96-hour infusional paclitaxel in patients with metastatic colorectal cancer

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    35. SHAW LM; MICK R; NOWAK I; KORECKA M; BRAYMAN KL
      PHARMACOKINETICS OF MYCOPHENOLIC-ACID IN RENAL-TRANSPLANT PATIENTS WITH DELAYED GRAFT FUNCTION

      Journal of clinical pharmacology
    36. SHAW LM; KORECKA M; ARADHYE S; GROSSMAN R; BARKER C; NAJI A; BRAYMAN KL
      SCIENTIFIC PRINCIPLES FOR MYCOPHENOLIC-ACID THERAPEUTIC DRUG-MONITORING

      Transplantation proceedings
    37. KAPLAN B; GRUBER SA; NALLAMATHOU R; KATZ SM; SHAW LM
      DECREASED PROTEIN-BINDING OF MYCOPHENOLIC-ACID ASSOCIATED WITH LEUKOPENIA IN A PANCREAS TRANSPLANT RECIPIENT WITH RENAL-FAILURE

      Transplantation
    38. SCHULMAN SL; SHAW LM; JABS K; LEONARD MB; BRAYMAN KL
      INTERACTION BETWEEN TACROLIMUS AND CHLORAMPHENICOL IN A RENAL-TRANSPLANT RECIPIENT

      Transplantation
    39. O'Connor, KL; Shaw, LM; Mercurio, AM
      Release of cAMP gating by the alpha 6 beta 4 integrin stimulates lamellae formation and the chemotactic migration of invasive carcinoma cells

      JOURNAL OF CELL BIOLOGY
    40. WEI JY; SHAW LM; MERCURIO AM
      REGULATION OF MITOGEN-ACTIVATED PROTEIN-KINASE ACTIVATION BY THE CYTOPLASMIC DOMAIN OF THE ALPHA(6) INTEGRIN SUBUNIT

      The Journal of biological chemistry
    41. SHAW LM; MICK R; NOWAK I; KORECKA M; BRAYMAN KL
      MYCOPHENOLIC-ACID PHARMACOKINETICS IN RENAL-TRANSPLANT PATIENTS WITH DELAYED GRAFT FUNCTION

      Clinical pharmacology and therapeutics
    42. SHIPKOVA M; NIEDMANN PD; ARMSTRONG VW; SCHUTZ E; WIELAND E; SHAW LM; OELLERICH M
      SIMULTANEOUS DETERMINATION OF MYCOPHENOLIC-ACID AND ITS GLUCURONIDE IN HUMAN PLASMA USING A SIMPLE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY PROCEDURE

      Clinical chemistry
    43. SHAW LM; OELLERICH M
      THE ROLE OF THERAPEUTIC DRUG-MONITORING IN DISEASE MANAGEMENT - INTRODUCTION

      Clinical chemistry
    44. SHAW LM; KAPLAN B; BRAYMAN KL
      PROSPECTIVE INVESTIGATIONS OF CONCENTRATION - CLINICAL-RESPONSE FOR IMMUNOSUPPRESSIVE DRUGS PROVIDE THE SCIENTIFIC BASIS FOR THERAPEUTIC DRUG-MONITORING

      Clinical chemistry
    45. EDER AF; MCGRATH CM; DOWDY YG; TOMASZEWSKI JE; ROSENBERG FM; WILSON RB; WOLF BA; SHAW LM
      ETHYLENE-GLYCOL POISONING - TOXICOKINETIC AND ANALYTICAL FACTORS AFFECTING LABORATORY DIAGNOSIS

      Clinical chemistry
    46. KORECKA M; VANBREEMAN RB; SHAW LM
      THE INHIBITION OF HUMAN INOSINE MONOPHOSPHATE DEHYDROGENASE BY MYCOPHENOLIC-ACID GLUCURONIDE IS DUE TO THE PRESENCE OF TRACE QUANTITIES OF MYCOPHENOLIC-ACID

      Clinical chemistry
    47. SHAW LM
      PROCEEDING OF THE FRONTIERS-IN-IMMUNOSUPPRESSIVE-THERAPY-MEETING, VANCOUVER, NOVEMBER 8-9, 1997

      Clinical biochemistry
    48. OELLERICH M; ARMSTRONG VW; SCHUTZ E; SHAW LM
      THERAPEUTIC DRUG-MONITORING OF CYCLOSPORINE AND TACROLIMUS

      Clinical biochemistry
    49. SHAW LM; NICHOLLS A; HALE M; ARMSTRONG VW; OELLERICH M; YATSCOFF R; MORRIS RE; HOLT DW; VENKATARAMANAN R; HALEY J; HALLORAN P; ETTENGER R; KEOWN P; MORRIS RG
      THERAPEUTIC MONITORING OF MYCOPHENOLIC-ACID - A CONSENSUS PANEL REPORT

      Clinical biochemistry
    50. SHAW LM; KORECKA M; VANBREEMAN R; NOWAK I; BRAYMAN KL
      ANALYSIS, PHARMACOKINETICS AND THERAPEUTIC DRUG-MONITORING OF MYCOPHENOLIC-ACID

      Clinical biochemistry
    51. WILLIAMS PA; SHAW LM; PITT CW; VRECL M
      XYLUW, 2 GENES AT THE START OF THE UPPER PATHWAY OPERON OF TOL PLASMID PWW0, APPEAR TO PLAY NO ESSENTIAL PART IN DETERMINING ITS CATABOLIC PHENOTYPE

      Microbiology
    52. SHAW LM; WANG HH; TOKER A; MERCURIO AM
      THE ALPHA-6 BETA-4 IN INTEGRIN PROMOTES CARCINOMA INVASION BY ACTIVATING PHOSPHOINOSITIDE 3-KINASE

      Molecular biology of the cell
    53. OCONNOR KL; SHAW LM; MERCURIO AM
      INTEGRIN ALPHA-6-BETA-4 STIMULATES CHEMOTACTIC MIGRATION OF CARCINOMA-CELLS BY REGULATING CAMP METABOLISM

      Molecular biology of the cell
    54. WEI J; SHAW LM; MERCURIO AM
      REGULATION OF MAP KINASE ACTIVATION BY THE CYTOPLASMIC DOMAIN OF THE ALPHA-6 INTEGRIN SUBUNIT

      Molecular biology of the cell
    55. WEI JY; SHAW LM; MERCURIO AM
      INTEGRIN SIGNALING IN LEUKOCYTES - LESSONS FROM THE ALPHA(6)BETA(1) INTEGRIN

      Journal of leukocyte biology
    56. CHENG JWM; CHARLAND SL; SHAW LM; KOBRIN S; GOLDFARB S; STANEK EJ; SPINLER SA
      IS THE VOLUME OF DISTRIBUTION OF DIGOXIN REDUCED IN PATIENTS WITH RENAL DYSFUNCTION - DETERMINING DIGOXIN PHARMACOKINETICS BY FLUORESCENCE POLARIZATION IMMUNOASSAY

      Pharmacotherapy
    57. SHAW LM; OHANIAN J; HEAGERTY AM
      CALCIUM SENSITIVITY AND AGONIST-INDUCED CALCIUM SENSITIZATION IN SMALL ARTERIES OF YOUNG AND ADULT SPONTANEOUSLY HYPERTENSIVE RATS

      Hypertension
    58. SALM P; TAYLOR PJ; CLARK A; BALDERSON GA; GRYGOTIS A; NORRIS RLG; LYNCH SV; SHAW LM; POND SM
      HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY TANDEM MASS-SPECTROMETRY AS A REFERENCE FOR ANALYSIS OF TACROLIMUS TO ASSESS 2 IMMUNOASSAYS IN PATIENTS WITH LIVER AND RENAL-TRANSPLANTS

      Therapeutic drug monitoring
    59. NOWAK I; SHAW LM
      EFFECT OF MYCOPHENOLIC-ACID GLUCURONIDE AN INOSINE MONOPHOSPHATE DEHYDROGENASE-ACTIVITY

      Therapeutic drug monitoring
    60. SHAW LM; RABINOVITZ I; WANG HHF; TOKER A; MERCURIO AM
      ACTIVATION OF PHOSPHOINOSITIDE 3-OH KINASE BY THE ALPHA-6-BETA-4 INTEGRIN PROMOTES CARCINOMA INVASION

      Cell
    61. NOWAK I; WU J; BRAYMAN KL; SHAW LM
      IS THE GLUCURONIDE METABOLITE OF MPA PHARMACOLOGICALLY ACTIVE

      Transplantation proceedings
    62. WASIK MA; NOWAK I; ZHANG Q; SHAW LM
      SUPPRESSION OF PROLIFERATION AND TYROSINE-PHOSPHORYLATION OF JAK3, STAT5 IN MALIGNANT T-CELL LYMPHOMA-CELLS BY INHIBITORS OF IL-2 MEDIATED SIGNALING AND PHOSPHATIDIC-ACID BIOSYNTHESIS

      Laboratory investigation
    63. RABINOVITZ I; SHAW LM; MERCURIO AM
      REMODELING OF BASEMENT-MEMBRANE BY COLON-CARCINOMA CELLS IN-VITRO - AROLE FOR ALPHA-6 INTEGRINS

      Gastroenterology
    64. WEWER UM; SHAW LM; ALBRECHTSEN R; MERCURIO AM
      THE INTEGRIN ALPHA-6-BETA-1 PROMOTES THE SURVIVAL OF METASTATIC HUMANBREAST-CARCINOMA CELLS IN MICE

      The American journal of pathology
    65. BROOKOFF D; ROTONDO MF; SHAW LM; CAMPBELL EA; FIELDS L
      COCAETHYLENE LEVELS IN PATIENTS WHO TEST POSITIVE FOR COCAINE

      Annals of emergency medicine
    66. SHAW LM; BONNER H; LIEBERMAN R
      PHARMACOKINETIC PROFILE OF AMIFOSTINE

      Seminars in oncology
    67. ZHANG Q; NOWAK I; VONDERHEID EC; ROOK AH; KADIN ME; NOWELL PC; SHAW LM; WASIK MA
      ACTIVATION OF JAK STAT PROTEINS INVOLVED IN SIGNAL-TRANSDUCTION PATHWAY MEDIATED BY RECEPTOR FOR INTERLEUKIN-2 IN MALIGNANT T-LYMPHOCYTES DERIVED FROM CUTANEOUS ANAPLASTIC LARGE T-CELL LYMPHOMA AND SEZARY-SYNDROME/

      Proceedings of the National Academy of Sciences of the United Statesof America
    68. COONEY GF; SHAW LM; HEIFETS M; SELLERS P; MANCANO MA
      TACROLIMUS PHARMACOKINETICS (PK) IN RENAL TXP CANDIDATES USING A SENSITIVE ASSAY

      Clinical pharmacology and therapeutics
    69. COONEY GF; GREVEL JC; SHAW LM; HEIFETS M
      CYCLOSPORINE CIRCADIAN-RHYTHM MODELED BY NONMEM IN STABLE RENAL TXP RECIPIENTS

      Clinical pharmacology and therapeutics
    70. EDER AF; DOWDY YG; GARDINER JAM; WOLF BA; SHAW LM
      SERUM LACTATE AND LACTATE-DEHYDROGENASE IN HIGH-CONCENTRATIONS INTERFERE IN ENZYMATIC ASSAY OF ETHYLENE-GLYCOL

      Clinical chemistry
    71. SHAW LM; KAPLAN B; KAUFMAN D
      TOXIC EFFECTS OF IMMUNOSUPPRESSIVE DRUGS - MECHANISMS AND STRATEGIES FOR CONTROLLING THEM

      Clinical chemistry
    72. BERNARD DW; BOWMAN RL; GRIMM FA; WOLF BA; SIMSON MB; SHAW LM
      NIGHTTIME DOSING ASSURES POSTDISTRIBUTION SAMPLING FOR THERAPEUTIC DRUG-MONITORING OF DIGOXIN

      Clinical chemistry
    73. SHAW LM; CHAO C; WEWER UM; MERCURIO AM
      FUNCTION OF THE INTEGRIN ALPHA-6-BETA-1 IN METASTATIC BREAST-CARCINOMA CELLS ASSESSED BY EXPRESSION OF A DOMINANT-NEGATIVE RECEPTOR

      Cancer research
    74. ALMEIDA EC; CHEN MS; HUOVILA APJ; SHAW LM; MERCURIO AM; PRIMAKOFF P; MYLES DG; WHITE JM
      ALTERNATE AFFINITY STATES OF THE INTEGRIN ALPHA-6-BETA-1 SHOW PREFERENTIAL BINDING TO LAMININ OR SPERM

      Molecular biology of the cell
    75. SHAW LM; GEORGE PR; OLDHAM AA; HEAGERTY AM
      A COMPARISON OF THE EFFECT OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITION AND ANGIOTENSIN-II RECEPTOR ANTAGONISM ON THE STRUCTURAL-CHANGES ASSOCIATED WITH HYPERTENSION IN RAT SMALL ARTERIES

      Journal of hypertension
    76. SOLDIN SJ; SHAW LM; YATSCOFF RW
      PROCEEDINGS OF THE INTERNATIONAL CONSENSUS CONFERENCE ON IMMUNOSUPPRESSIVE DRUGS - LAKE-LOUISE, ALBERTA, CANADA - MAY 5-7, 1995

      Therapeutic drug monitoring
    77. SHAW LM; ANNESLEY TM; KAPLAN B; BRAYMAN KL
      ANALYTIC REQUIREMENTS FOR IMMUNOSUPPRESSIVE DRUGS IN CLINICAL-TRIALS

      Therapeutic drug monitoring
    78. SHAW LM; NOWAK I
      MYCOPHENOLIC-ACID - MEASUREMENT AND RELATIONSHIP TO PHARMACOLOGICAL EFFECTS

      Therapeutic drug monitoring
    79. SHAW LM; SOLLINGER HW; HALLORAN P; MORRIS RE; YATSCOFF RW; RANSOM J; TSINA I; KEOWN P; HOLT DW; LIEBERMAN R; JAKLITSCH A; POTTER J
      MYCOPHENOLATE MOFETIL - A REPORT OF THE CONSENSUS PANEL

      Therapeutic drug monitoring
    80. ALMEIDA EAC; HUOVILA APJ; SUTHERLAND AE; STEPHENS LE; CALARCO PG; SHAW LM; MERCURIO AM; SONNENBERG A; PRIMAKOFF P; MYLES DG; WHITE JM
      MOUSE EGG INTEGRIN ALPHA-6-BETA-1 FUNCTIONS AS A SPERM RECEPTOR

      Cell
    81. HEIFETS M; COONEY GF; SHAW LM; LIBETTI G
      DIURNAL-VARIATION OF CYCLOSPORINE CLEARANCE IN STABLE RENAL-TRANSPLANT RECIPIENTS RECEIVING CONTINUOUS-INFUSION

      Transplantation
    82. BENJOSEF E; MESINA J; SHAW LM; BONNER HS; SHAMSA F; PORTER AT
      TOPICAL APPLICATION OF WR-2721 ACHIEVES HIGH-CONCENTRATIONS IN THE RECTAL WALL

      Radiation research
    83. SHAW LM; TURNER CE; MERCURIO AM
      THE ALPHA-6A-BETA-1-INTEGRIN AND ALPHA-6B-BETA-1-INTEGRIN VARIANTS SIGNAL DIFFERENCES IN THE TYROSINE PHOSPHORYLATION OF PAXILLIN AND OTHERPROTEINS

      The Journal of biological chemistry
    84. NOWAK I; SHAW LM
      MYCOPHENOLIC-ACID BINDING TO HUMAN SERUM-ALBUMIN - CHARACTERIZATION AND RELATION TO PHARMACODYNAMICS

      Clinical chemistry
    85. SHAW LM; MERCURIO AM
      REGULATION OF CELLULAR INTERACTIONS WITH LAMININ BY INTEGRIN CYTOPLASMIC DOMAINS - THE A AND B STRUCTURAL VARIANTS OF THE ALPHA-6-BETA-1 INTEGRIN DIFFERENTIALLY MODULATE THE ADHESIVE STRENGTH, MORPHOLOGY, AND MIGRATION OF MACROPHAGES

      Molecular biology of the cell
    86. MATTES RD; SHAW LM; ENGELMAN K
      EFFECTS OF CANNABINOIDS (MARIJUANA) ON TASTE INTENSITY AND HEDONIC RATINGS AND SALIVARY FLOW OF ADULTS

      Chemical senses
    87. COONEY GF; HEIFETS M; BELL A; SHAW LM; LIBETTI G
      UTILITY OF PRETRANSPLANTATION CYCLOSPORINE PHARMACOKINETIC STUDIES

      Therapeutic drug monitoring
    88. SIMMONS D; SHAW LM; SCOTT DJ; KENEALY T; SCRAGG RK
      DIABETIC NEPHROPATHY AND MICROALBUMINURIA IN THE COMMUNITY - THE SOUTH AUCKLAND DIABETES SURVEY

      Diabetes care
    89. MATTES RD; ENGELMAN K; SHAW LM; ELSOHLY MA
      CANNABINOIDS AND APPETITE STIMULATION

      Pharmacology, biochemistry and behavior
    90. SHAW LM; BONNER HS; BROWN DQ
      METABOLIC PATHWAYS OF WR-2721 (ETHYOL, AMIFOSTINE) IN THE BALB C MOUSE/

      Drug metabolism and disposition
    91. SHAW LM; ANNESLEY T; GILMORE B; BRAYMAN K
      MEASUREMENT OF OG37-325 BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY

      Transplantation proceedings
    92. SHAW LM; BRAYMAN KL
      FK-506 THERAPEUTIC DRUG-MONITORING

      Clinical chemistry
    93. ROBY KAW; SHAW LM
      EFFECTS OF CYCLOSPORINE AND ITS METABOLITES IN THE ISOLATED-PERFUSED RAT-KIDNEY

      Journal of the American Society of Nephrology
    94. MESSIER JM; SHAW LM; CHAFEL M; MATSUDAIRA P; MERCURIO AM
      FIMBRIN LOCALIZED TO AN INSOLUBLE CYTOSKELETAL FRACTION IS CONSTITUTIVELY PHOSPHORYLATED ON ITS HEADPIECE DOMAIN IN ADHERENT MACROPHAGES

      Cell motility and the cytoskeleton
    95. SHAW LM
      PROCEEDINGS OF THE 3RD INTERNATIONAL-CONGRESS OF THERAPEUTIC DRUG-MONITORING AND CLINICAL TOXICOLOGY

      Therapeutic drug monitoring
    96. SHAW LM; BONNER HS; FIELDS L; LIEBERMAN R
      THE USE OF CONCENTRATION MEASUREMENTS OF PARENT DRUG AND METABOLITES DURING CLINICAL-TRIALS

      Therapeutic drug monitoring
    97. SHAW LM; MERCURIO AM
      REGULATION OF ALPHA-6-BETA-1-INTEGRIN LAMININ RECEPTOR FUNCTION BY THE CYTOPLASMIC DOMAIN OF THE ALPHA-6-SUBUNIT

      The Journal of cell biology
    98. SHAW LM; LOTZ MM; MERCURIO AM
      INSIDE-OUT INTEGRIN SIGNALING IN MACROPHAGES - ANALYSIS OF THE ROLE OF THE ALPHA-6A-BETA-1 AND ALPHA-6B-BETA-1 INTEGRIN VARIANTS IN LAMININADHESION BY CDNA EXPRESSION IN AN ALPHA-6 INTEGRIN-DEFICIENT MACROPHAGE CELL-LINE

      The Journal of biological chemistry


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/10/20 alle ore 18:44:58